Terms: = Bone cancer AND LIFR, SJS2, 3977, ENSG00000113594, SWS, STWS, CD118
20 results:
1. PTHrP intracrine actions divergently influence breast cancer growth through p27 and lifr.
Edwards CM; Kane JF; Smith JA; Grant DM; Johnson JA; Diaz MAH; Vecchi LA; Bracey KM; Omokehinde TN; Fontana JR; Karno BA; Scott HT; Vogel CJ; Lowery JW; Martin TJ; Johnson RW
Breast Cancer Res; 2024 Feb; 26(1):34. PubMed ID: 38409028
[TBL] [Abstract] [Full Text] [Related]
2. WEE1 inhibitor adavosertib in combination with carboplatin in advanced TP53 mutated ovarian cancer: A biomarker-enriched phase II study.
Embaby A; Kutzera J; Geenen JJ; Pluim D; Hofland I; Sanders J; Lopez-Yurda M; Beijnen JH; Huitema ADR; Witteveen PO; Steeghs N; van Haaften G; van Vugt MATM; de Ridder J; Opdam FL
Gynecol Oncol; 2023 Jul; 174():239-246. PubMed ID: 37236033
[TBL] [Abstract] [Full Text] [Related]
3. Parathyroid hormone-related protein in breast cancer bone metastasis.
Johnson RW; Rhoades J; Martin TJ
Vitam Horm; 2022; 120():215-230. PubMed ID: 35953110
[TBL] [Abstract] [Full Text] [Related]
4. Associations Between Late Pregnancy Dietary Inflammatory Index (DII) and Offspring bone Mass: A Meta-Analysis of the Southampton Women's Survey (sws) and the Avon Longitudinal Study of Parents and Children (ALSPAC).
Woolford SJ; D'Angelo S; Mancano G; Curtis EM; Ashai S; Shivappa N; Hébert JR; Crozier SR; Phillips CM; Suderman M; Relton CL; Cooper C; Harvey NC;
J Bone Miner Res; 2022 Aug; 37(8):1511-1519. PubMed ID: 35689423
[TBL] [Abstract] [Full Text] [Related]
5. gp130 Cytokines Activate Novel Signaling Pathways and Alter bone Dissemination in ER+ Breast cancer Cells.
Omokehinde T; Jotte A; Johnson RW
J Bone Miner Res; 2022 Feb; 37(2):185-201. PubMed ID: 34477239
[TBL] [Abstract] [Full Text] [Related]
6. HDAC inhibitors induce lifr expression and promote a dormancy phenotype in breast cancer.
Clements ME; Holtslander L; Edwards C; Todd V; Dooyema SDR; Bullock K; Bergdorf K; Zahnow CA; Connolly RM; Johnson RW
Oncogene; 2021 Aug; 40(34):5314-5326. PubMed ID: 34247191
[TBL] [Abstract] [Full Text] [Related]
7. Regulation of bone metastasis and metastasis suppressors by non-coding RNAs in breast cancer.
Sanjeev G; Pranavkrishna S; Akshaya RL; Rohini M; Selvamurugan N
Biochimie; 2021 Aug; 187():14-24. PubMed ID: 34019953
[TBL] [Abstract] [Full Text] [Related]
8. STAT3 phosphorylation at Ser727 and Tyr705 differentially regulates the EMT-MET switch and cancer metastasis.
Lin WH; Chang YW; Hong MX; Hsu TC; Lee KC; Lin C; Lee JL
Oncogene; 2021 Jan; 40(4):791-805. PubMed ID: 33262462
[TBL] [Abstract] [Full Text] [Related]
9. Hodgkin lymphoma transformation of chronic lymphocytic leukemia-A real life data from the Polish Lymphoma Research Group.
Drozd-Sokołowska J; Zaucha JM; Żółtak T; Jamroziak K; Grzybowska-Izydorczyk O; Witkowska M; Waszczuk-Gajda A; Kaźmierczak M; Szczepaniak A; Subocz E; Knopińska-Posłuszny W; Hołojda J; Kopińska A; Hus I; Rybka J; Wołowiec D; Kwiatkowski J; Hałaburda K; Smolewski P; Giebel S; Wiktor-Jędrzejczak W
Hematol Oncol; 2019 Oct; 37(4):383-391. PubMed ID: 31026087
[TBL] [Abstract] [Full Text] [Related]
10. Feasibility of whole body vibration during intensive chemotherapy in patients with hematological malignancies - a randomized controlled pilot study.
Pahl A; Wehrle A; Kneis S; Gollhofer A; Bertz H
BMC Cancer; 2018 Sep; 18(1):920. PubMed ID: 30253746
[TBL] [Abstract] [Full Text] [Related]
11. A mandatory role of nuclear PAK4-lifr axis in breast-to-bone metastasis of ERα-positive breast cancer cells.
Li Y; Zhang H; Zhao Y; Wang C; Cheng Z; Tang L; Gao Y; Liu F; Li J; Li Y; Li Y; Geng N; Rui X; Teng Y; Liu Y; Cao L; Kumar R; Jin F; Li F
Oncogene; 2019 Feb; 38(6):808-821. PubMed ID: 30177834
[TBL] [Abstract] [Full Text] [Related]
12. Molecular changes in bone marrow, tumor and serum after conductive ablation of murine 4T1 breast carcinoma.
Przybyla BD; Shafirstein G; Vishal SJ; Dennis RA; Griffin RJ
Int J Oncol; 2014 Feb; 44(2):600-8. PubMed ID: 24270800
[TBL] [Abstract] [Full Text] [Related]
13. Do baseline Cereblon gene expression and IL-6 receptor expression determine the response to thalidomide-dexamethasone treatment in multiple myeloma patients?
Bedewy AM; El-Maghraby SM
Eur J Haematol; 2014 Jan; 92(1):13-8. PubMed ID: 24118365
[TBL] [Abstract] [Full Text] [Related]
14. Oncostatin M is a growth factor for Ewing sarcoma.
David E; Tirode F; Baud'huin M; Guihard P; Laud K; Delattre O; Heymann MF; Heymann D; Redini F; Blanchard F
Am J Pathol; 2012 Nov; 181(5):1782-95. PubMed ID: 22982441
[TBL] [Abstract] [Full Text] [Related]
15. Breast cancer medications and vision: effects of treatments for early-stage disease.
Eisner A; Luoh SW
Curr Eye Res; 2011 Oct; 36(10):867-85. PubMed ID: 21819259
[TBL] [Abstract] [Full Text] [Related]
16. Leukemia inhibitory factor: a newly identified metastatic factor in rhabdomyosarcomas.
Wysoczynski M; Miekus K; Jankowski K; Wanzeck J; Bertolone S; Janowska-Wieczorek A; Ratajczak J; Ratajczak MZ
Cancer Res; 2007 Mar; 67(5):2131-40. PubMed ID: 17332343
[TBL] [Abstract] [Full Text] [Related]
17. The migration of bone marrow-derived non-hematopoietic tissue-committed stem cells is regulated in an SDF-1-, HGF-, and LIF-dependent manner.
Kucia M; Wojakowski W; Reca R; Machalinski B; Gozdzik J; Majka M; Baran J; Ratajczak J; Ratajczak MZ
Arch Immunol Ther Exp (Warsz); 2006; 54(2):121-35. PubMed ID: 16648972
[TBL] [Abstract] [Full Text] [Related]
18. A phase II trial of weekly paclitaxel and gemctiabine infused at a constant rate in patients with advanced non-small cell lung cancer.
Gillenwater HH; Stinchcombe TE; Qaqish BF; Tyann M; Hensing TA; Socinski MA
Lung Cancer; 2005 Mar; 47(3):413-9. PubMed ID: 15713525
[TBL] [Abstract] [Full Text] [Related]
19. Functional expression of soluble human interleukin-11 (IL-11) receptor alpha and stoichiometry of in vitro IL-11 receptor complexes with gp130.
Neddermann P; Graziani R; Ciliberto G; Paonessa G
J Biol Chem; 1996 Nov; 271(48):30986-91. PubMed ID: 8940087
[TBL] [Abstract] [Full Text] [Related]
20. Phase II study of prolonged oral etoposide in combination with intravenous cisplatin in advanced non-small cell lung cancer.
Miller AA; Niell HB; Griffin JP
Lung Cancer; 1995 Mar; 12(1-2):59-65. PubMed ID: 7600031
[TBL] [Abstract] [Full Text] [Related]
